This article may be too technical for most readers to understand. (May 2020) |
| ATAD3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | ATAD3B, AAA-TOB3, TOB3, ATPase family, AAA domain containing 3B, ATPase family AAA domain containing 3B | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 612317; GeneCards: ATAD3B | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ATAD3B | |
|---|---|
| Alliases | TOB3, AAA-TOB3, KIAA 1273 |
| External IDs | NCBI: AAH02542.1 |
| Gene Location (Human) | |
ATPase family AAA domain-containing protein 3B (or ATAD3B) is a protein that in humans is encoded by the ATAD3B gene. ATAD3 is part of the AAA protein family. The function of ATAD3B is not yet well understood by the scientific community.

ATAD3B is associated with the mitochondria. The C terminus is anchored in the mitochondrial inter membrane space.
The protein is linked with the pluripotency of stem cells. The ATAD3A gene is targeted by c-Myc which is one of four factors needed to create induced pluripotent stem (i-PS) cells from mouse embryonic fibroblasts (MEFs).
Its expression is linked to cell cycle function and tumor growth. When ATAD3B was overexpressed, cell duplication took an extra three hours by spending a longer time in G1 phase.
A mutation in the stop codon means that ATAD3B protein 62 amino acids longer at the C-terminus compared to ATAD3A. This C-terminal extension of ATAD3B turns it into a negative regulator of ATAD3A.
Abnormal expression levels of ATAD3B has been linked to chemoresistance. Overexpression of ATAD3B was the found to be the strongest factor in breast cancer survival rates.